Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for Endothelial Dysfunction in CKD
NCT02133534Phase 4Terminated
- Sponsor
- Duke University
- Start
- Feb 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of atorvastatin in hyperlipidemia, sponsored by Duke University. Primary endpoint: Improved Counts of Endothelial Progenitor Cells at 30 days. Started Feb 2008; status: terminated.
02
Drugs
atorvastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02133534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02133534.